The analysis of γ-glutamyl transpeptidase gene in different type liver tissues

Table 1 Incidence of Different GGTmRNA types in Livers of Each Group

Group	No. of Samples	Type of GGTmRNA
		A (%)	B (%)	C (%)
1.Normal	12	12 (100%)	0	3 (25.00%)
2.Acute hepatitis	15	14 (93.33%)	1 (6.67%)	2 (13.33%)
3.Chronic hepatitis	18	16 (88.89%)	3 (16.67%)	4 (22.22%)
4.Cirrosis	11	9 (81.82%)	3 (27.27%)	2 (18.18%)
5.Alcoholic hepatopathy	13	12 (92.31%)	1 (7.69%)	3 (23.08%)
6.Hepatic benign tumor	10	10 (100%)	0	1 (10.00%)
7.Secondary carcinoma of liver	13	11 (84.62%)	0	3 (23.08%)
8.HCC	32
Cancerous tissues	32	15 (46.88%)a	28 (87.5%)a	2 (6.25%)
Adjacent Paracancerous tissues	21	18 (85.71%)	17 (80.95%)a	3 (14.29%)
Distal Cancerous tissues	21	19 (90.48%)	16 (76.19%)a	2 (9.52%)
Noncancerous tissues	11	9 (81.82%)	8 (72.73%)a	1 (9.09%)

^aP < 0.05 vs. normal liver.

Table 2 GGTmRNA and the size of HCC

	cases	Cancerous tissues type A	Cancerous tissues type B	Non cancerous tissues type B	Peripheral blood type B
Small sized HCC	8	5 (62.50%)	6 (75.00%)	5 (62.50%)	2 (25.00%)
Large sized HCC	16	7 (43.75%)	15 (93.75%)	14 (87.50%)	6 (37.50%)
Enormous sized HCC	8	3 (37.50%)	7 (87.50%)	7 (87.50%)	4 (50.00%)